← Leaderboards
Jonathan M Covault
University Of Connecticut Sch Of Med/Dnt
$7,325,948
Attributed
$7,325,948
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $904.4K · FY2006–23$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,325,948 · 12
By mechanism
P50$2,376,458 · 1
R01$1,773,998 · 1
R21$1,579,643 · 2
P60$1,378,650 · 1
M01$217,199 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Richard H Fortinsky$8,098,374
- Thomas F Babor$7,980,551
- Sumit Yadav$3,029,233
Others in their field
Top investigators on “Alleles”
- Richard A Gibbs · Baylor College Of Medicine$162,061,189
- Eric S Lander · Whitehead Institute For Biomedical Res$88,310,092
- Kc Kent Lloyd · University Of California At Davis$73,526,404
- Michael A Province · Washington University$68,289,985
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard J O'Reilly · Sloan-Kettering Institute For Cancer Res$51,945,604
Research focus
AllelesGenesAlcoholsResponseGenotypeHuman SubjectClinical ResearchAlcohol EffectGenetic MarkersAlcohol DependenceAlcohol AbuseGeneticAlcohol Use DisorderProblem DrinkerBehavioral GeneticsAlcohol Abuse TherapyProductionDutasterideMediatingPharmaceutical PreparationsVariation (Genetics)DrinkingOxidoreductaseDesign
Grant awards (41)
Dutasteride treatment for reducing heavy drinking in AUD: Predictors of efficacy$452,973
P50 · FY2023 · AA · contact PI
Dutasteride treatment for reducing heavy drinking in AUD: Predictors of efficacy$485,997
P50 · FY2022 · AA · contact PI
Dutasteride treatment for reducing heavy drinking in AUD: Predictors of efficacy$477,966
P50 · FY2021 · AA · contact PI
Dutasteride treatment for reducing heavy drinking in AUD: Predictors of efficacy$484,484
P50 · FY2020 · AA · contact PI
Dutasteride treatment for reducing heavy drinking in AUD: Predictors of efficacy$475,038
P50 · FY2019 · AA · contact PI
Dutasteride treatment for the reduction of heavy drinking$248,366
P60 · FY2017 · AA · contact PI
Dutasteride treatment for the reduction of heavy drinking$287,203
P60 · FY2016 · AA · contact PI
Dutasteride treatment for the reduction of heavy drinking$277,246
P60 · FY2015 · AA · contact PI
Pharmacogenetics of alcohol treatment: Topiramate and GRIK1$186,002
R21 · FY2015 · AA · contact PI
Dutasteride treatment for the reduction of heavy drinking$277,943
P60 · FY2014 · AA · contact PI
Pharmacogenetics of alcohol treatment: Topiramate and GRIK1$230,842
R21 · FY2014 · AA · contact PI
Dutasteride treatment for the reduction of heavy drinking$287,892
P60 · FY2013 · AA · contact PI
Novel Methods to Study Substance Use in College Students$295,024
R21 · FY2010 · AA · contact PI
Pharmacogenetics of Alcohol: Treatment Implications$414,179
R01 · FY2009 · AA · contact PI
Novel Methods to Study Substance Use in College Students$290,799
R21 · FY2009 · AA · contact PI
Pharmacogenetics of Alcohol: Treatment Implications$410,170
R01 · FY2008 · AA · contact PI
Novel Methods to Study Substance Use in College Students$280,490
R21 · FY2008 · AA · contact PI
Pharmacogenetics of Alcohol: Treatment Implications$110,834
R01 · FY2008 · AA · contact PI
DA1C$55,058
M01 · FY2008 · RR · contact PI
ALCOHOL CHALLENGE$47,894
M01 · FY2008 · RR · contact PI
Pharmacogenetics of Alcohol: Treatment Implications$411,122
R01 · FY2007 · AA · contact PI
Novel Methods to Study Substance Use in College Students$296,486
R21 · FY2007 · AA · contact PI
ALCOHOL CHALLENGE$31,526
M01 · FY2007 · RR · contact PI
PHARMACOKINETIC STUDY$30,271
M01 · FY2007 · RR · contact PI
GABRA2$157
M01 · FY2007 · RR · contact PI
Pharmacogenetics of Alcohol: Treatment Implications$427,693
R01 · FY2006 · AA · contact PI
Genetic Correlates of Sensory Trait Markers in Schizophrenia$5,349
M01 · FY2004 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$0
M01 · FY2002 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$0
M01 · FY2002 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$4,361
M01 · FY2001 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$4,361
M01 · FY2001 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$0
M01 · FY2001 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$0
M01 · FY2001 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$0
M01 · FY2001 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$0
M01 · FY2001 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$19,111
M01 · FY2000 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$19,111
M01 · FY2000 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$0
M01 · FY2000 · RR
GENETIC ASSOCIATIONS OF CANNABINOID RECEPTOR ALLELES IN DRUG DEPENDEN$0
M01 · FY2000 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$0
M01 · FY2000 · RR
GENETIC CORRELATES OF SENSORY TRAIT MARKERS IN SCHIZOPHRENIA$0
M01 · FY2000 · RR